1-1 of 1
for the Liraglutide Effect Action in Diabetes (LEAD)-6 Study Group
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents

John B. Buse, MD, PHD, Giorgio Sesti, MD, Wolfgang E. Schmidt, MD, PHD, Eduard Montanya, MD, PHD, Cheng-Tao Chang, PHD, Yizhen Xu, MD, PHD, Lawrence Blonde, MD, Julio Rosenstock, MD, for the Liraglutide Effect Action in Diabetes (LEAD)-6 Study Group
Journal: Diabetes Care
Diabetes Care 2010;33(6):1300–1303
https://doi.org/10.2337/dc09-2260
Published: 23 March 2010
View article titled, Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
Open the PDF for Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents in another window
Includes: Supplementary data